← All T2 Biosystems, INC filings

T2 Biosystems, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

OTC.Pink
TTOO
T2 Biosystems, INC
DEF: T2 Biosystems Seeks Stockholder Approval for Reverse Stock Split to Maintain Nasdaq Listing
T2 Biosystems is asking shareholders to approve a reverse stock split, with a ratio between 1-for-10 and 1-for-100, to regain compliance with Nasdaq's minimum bid price requirement.
OTC.Pink
TTOO
T2 Biosystems, INC
DEF 14A: T2 Biosystems Sets Date for 2024 Annual Stockholders Meeting, Proposes Director Elections and Incentive Plan Changes
T2 Biosystems will hold its 2024 Annual Meeting of Stockholders virtually on December 30, 2024, to vote on director elections, an incentive plan amendment, and the ratification of its independent auditor.
OTC.Pink
TTOO
T2 Biosystems, INC
DEF 14A: T2 Biosystems Seeks Stockholder Approval for CRG Debt-to-Equity Conversion
T2 Biosystems is asking stockholders to approve a debt-to-equity conversion with CRG that could result in CRG owning a significant portion of the company's common stock.